SCHEDULE 13G - 10-02-2000 - VERTEX PHARMACEUTICALS

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

October 3, 2000

Accession Number

0000315066-00-001217

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →